Stay Ahead of the Curve with these valuable continuing education resources
for the Cystic Fibrosis Care Team

Chronic Cystic Fibrosis Respiratory Infections: Where do we go from here?

Journal Supplement

This supplement provides a historical perspective on the development of aerosol antibiotics & the treatment strategies used in clinical trials. The authors challenge this strategy, offering evidence to support continuous antibiotic treatment.

Go to  website

eCysticFibrosis Review, Volume 3

NEWSLETTER / PODCAST SERIES

Monthly emailed newsletter and case-based podcast series. Authored by CF experts, who present a concise review of the relevant journal literature on a single topic. The companion podcast applies the literature
to your clinical practice.

Go to  website

AOTC: Genetics Revolution

INTERACTIVE CASE-BASED PRESENTATION

What you need to know today to be ready for tomorrow. Watch our faculty at ECFS as they translate the science of CFTR-Modifying Therapies into clinical practice.

Go to Program

AOTC: Emerging CF Therapies 2009

WEBCASTS FROM A LIVE SYMPOSIA

There are more potential therapies in development today than in the entire history of CF research. Watch our Hopkins faculty as they discuss these new therapies.

Go to Program

AOTC: Genetics Revolution for the
CF Care Team

INTERACTIVE CASE-BASED PRESENTATION

International faculty translates the relationship between the CF genotype and phenotype of environment and adherence, with perspective
from the entire CF Care Team.

Go to Program

Video Blog: Questions for the CF Care Team

INTERACTIVE VIDEO BLOG

This blog continues the conversation with the faculty to provide ongoing, highly relevant video posts by our expert CF Team. These posts will follow up on questions that did not get answered during the symposium as well as other issues of significance.

Go to Blog

AOTC: CF Summit

WEBCAST SERIES

Join the conversation with our international faculty as they discuss the latest guidelines, emerging therapies, and perspectives on treating lung disease lung disease in patients with CF.

Go to Program